November
Bioinformatics
&
Drug Discovery Biology
Strategy Meeting East Coast USA 2025
days
hours
minutes
seconds
What makes our strategy meetings unique?

Roundtable Discussions
Intimate discussions led by renowned industry experts. Have your voice heard and debate alongside like-minded life science executives.

Unrivalled Networking
With senior delegation from big pharma and innovative biotech from across the East Coast, you can network with peers from different locations, all in one place.

Personalised Agenda
Choose the topics that matter to you. Reserve your place at the roundtable discussions and ensure your whole day delivers the insights you need to hear.

Solutions to your Problems
We've partnered with the best solution providers to solve your biggest challenges. Engage in pre-arranged, private meetings to address your specific needs and find a tangible solution.

Industry Researched Topics
We guarantee our agenda is up-to-date and mission critical because its designed by you. We speak to our extended network of senior decision makers to ensure the most important topics are discussed.

Senior Decision Makers
The entire strategy meeting is specifically tailored to the needs and challenges of senior life science professionals. Discover how your peers are dealing with the same challenges as you.
Our Facilitators
Our panel of facilitators play a key role in shaping the agenda for the day. See who will be bringing their expertise to the table at our upcoming strategy meeting.

Allen Hopper
VP Drug Discovery Lucy Therapeutics
Ananthsrinivas Rao Chakilam
Vice President, Drug Metabolism and Pharmacokinetics Abbvie

Basma Hashmi
Head, Digital Solutions Takeda

David Sherris
CEO Attivare Therapeutics

Diane Joseph-McCarthy
Executive Director, Bioengineering Technology & Entrepreneurship Center Boston University

Govinda Bhisetti
Vice President and Head of Computational Chemistry Cellarity

Jeron Chen
Director and Head of Data Science Voyager Therapeutics, Inc.

Katrina Loomis
Executive Director, Head of Emerging Science Genetics Pfizer

Lijuan Jiang
Vice President, DMPK & Bioanalysis Enanta Pharmaceuticals

Mohamed Kassam
Head of Bioinformatics Zifo

Mohammad Shadid
Vice President, Preclinical and Translational Sciences Korro Bio

Prasoon Chaturvedi
Vice President, Head of DMPK C4 Therapeutics, Inc.


Sylvie Mireille Guichard
Vice President Rare Disease Research Novo NordiskOur Agenda
See Which Topics Are Discussed at the Strategy Meeting
Roundtable Tracks
1Overcoming Limitations in Chemical Proteomics for Comprehensive Target Identification (Topic TBC)
-Allen Hopper
VP Drug Discovery
Lucy Therapeutics
DMPK / ADME Toxicology
Bridging Preclinical Models and Human Safety: Innovations in DMPK and Toxicology (Topic TBC)
-Mohammad Shadid
Vice President, Preclinical and Translational Sciences
Korro Bio
In Vivo and In Vitro Pharmacology
Improving Translational Predictability: Enhancing PK/PD Models, Biomarkers, and Multi- Scale Integration in Preclinical Pharmacology
Data Management, Big Data & Digital Transformation
Accelerating Bioinformatics Pipelines with Next-Generation Data Platforms: Lessons from High-Performance Infrastructure at Scale
Data Management, Big Data & Digital Transformation
Building Robust AI Models for Improved Data Quality and Representation in Drug Discovery
Private Equity, Venture Capital & Strategic ESTPartnerships
What Are the Emerging Trends in Venture Capital for Drug Discovery and Biotech Startups?
Roundtable Tracks
2Addressing the Complexities of Multi-Target Drug Design through Pharmacophore and Proteomic Profiling
SAI LIFE SCIENCES
DMPK / ADME ToxicologyOptimizing Drug Development through Pharmacokinetic Prediction for Enhanced Drug Efficacy
Sponsor
In Vivo and In Vitro PharmacologyEnhancing preclinical dose projection with appropriate biomarkers to facilitate clinical development
Sponsor
Data Management, Big Data & Digital TransformationRole of Cloud Computing in Scalable Bioinformatics and Accelerating Drug Discovery Pipelines
REVVITY SIGNALS
Data Management, Big Data & Digital TransformationFrom Clusters to Cloud: Architecting High-Performance Storage for AI, Life Sciences, and the Next Wave of HPC Workloads
REVVITY SIGNALS
Private Equity, Venture Capital & Strategic ESTPartnershipsEarly-Stage Science, Late-Stage Discipline: What Today’s Investors Want
Sponsor
Roundtable Tracks
3Using Computational Methods to Improve Precision and Efficiency in Lead Optimization and Hit Identification (Topic TBC)
-Govinda Bhisetti
Vice President and Head of Computational Chemistry
Cellarity
DMPK / ADME Toxicology
Developments in Predictive Modeling and Metabolic Profiling for Advancing Drug Discovery with DMPK (Topic TBC)
-Prasoon Chaturvedi
Vice President, Head of DMPK
C4 Therapeutics, Inc.
In Vivo and In Vitro Pharmacology
Emerging In Vivo Alternatives: Balancing Ethics and Biological Complexity
Data Management, Big Data & Digital Transformation
Accelerating Bioinformatics Pipelines with Next-Generation Data Platforms: Lessons from High-Performance Infrastructure at Scale
Data Management, Big Data & Digital Transformation
Innovating In Silico Drug Design through AI and ML
Private Equity, Venture Capital & Strategic ESTPartnerships
Strategic Alliances and Investment Strategies: Fueling the Future of Drug Discovery
Roundtable Tracks
4Navigating the Integration of Artificial Intelligence in Drug Target Discovery (Topic TBC)
-Ananthsrinivas Rao Chakilam
Vice President, Drug Metabolism and Pharmacokinetics
Abbvie
DMPK / ADME Toxicology
Strategies to Optimize ADME Properties in Drug Discovery to Enhance Drug Bioavailability
-Lijuan Jiang
Vice President, DMPK & Bioanalysis
Enanta Pharmaceuticals
In Vivo and In Vitro Pharmacology
Advanced In Vitro Models Enhancing Predictive Accuracy in Drug Discovery
Data Management, Big Data & Digital Transformation
Bridging the Data Divide in Bioinformatics: Innovative Approaches to Data Management and Analysis
Data Management, Big Data & Digital Transformation
AI-Powered Drug Discovery Trends and Challenges in 2025 (Topic TBC)
-Diane Joseph-McCarthy
Executive Director, Bioengineering Technology & Entrepreneurship Center
Boston University
Private Equity, Venture Capital & Strategic ESTPartnerships
Partnering for Progress: How Big Pharma & Biotech Forge the Next Wave of Innovation
Reasons To Attend Our Strategy Meetings


Fully Interactive Format
There's only so much you can learn from presentations and lectures. Instead our interactive Roundtable Discussions let you debate the topics that really matter


Senior Decision Makers
All our Strategy Meetings are aimed at director level and above. Discover how your peers are tackling the industries biggest challenges and have your thoughts heard


Personalised Agendas
Pick the roundtable discussions that you want to be part of. Simply choose your sessions and we'll create a personalised agenda just for you


Private and Intimate Networking
Small group discussions, private meetings, networking drinks - however you choose to make those important connections our Strategy Meetings have the solution
Event Gallery
Press play to hear what your colleagues had to say...










Hotel & Venue
Le Méridien Boston Cambridge
Le Méridien Cambridge-MIT’s elegant guest rooms and suites offer a place of luxurious sanctuary and unmatched comfort. Explore unique programs inspired by the brand’s European heritage. Born in a glamorous era of travel, Le Méridien believes everyone should explore the world in style.
Hotel Details Maps & Direction Parking









Want to find out more?
Find out more details about our Strategy Meetings and other news and events.
Here To Help
Want to know more? Interested in sponsoring the event? Need help registering your team?rnrnJust get in touch and a member of the team will be happy to help.